SUGAR LAND, Texas, Jan. 18, 2022 /PRNewswire/ QuVa Pharma, Inc., a leading national 503B outsourcing services company to U.S. hospitals, and its parent company, QuVa Pharma Holdings, Inc. .
/PRNewswire/ QuVa Pharma, Inc., a leading national 503B outsourcing services company to U.S. hospitals, and its parent company, QuVa Pharma Holdings, Inc..
/PRNewswire/ QuVa Pharma, Inc., a leading national 503B outsourcing services company to U.S. hospitals, and its parent company, QuVa Pharma Holdings, Inc..
The gene therapy pipeline of Voyager Therapeutics has hit several setbacks in the past year, but a strategy shift to its capsid technology is now showing promise. Pfizer has signed on as partner in a wager that Voyager’s tech holds the key to delivery of gene therapies for cardiovascular and neurological disorders.